Topic

Natpara (parathyroid hormone)

A collection of 31 issues

Lowering Out-of-Pocket for Natpara (Parathyroid Hormone) with Humana in Florida: Copay, Tiering & Assistance

Answer Box: Getting Natpara (Parathyroid Hormone) Covered by Humana in Florida Important Update: Natpara is no longer commercially available as Takeda discontinued manufacturing in December 2024, with the Special Use Program ending December 31, 2025. New prescriptions are automatically denied. If you're currently on Natpara, work with your

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in New Jersey: 2025 Timeline and Appeals Guide

Answer Box: Quick Start Guide Getting Natpara covered by Cigna in New Jersey requires prior authorization with specific documentation. Under New Jersey's 2025 law, Cigna must respond within 9 days for electronic submissions or 12 days for paper. The fastest path: Have your endocrinologist submit through CignaforHCP.com

Denied for Natpara by UnitedHealthcare in New Jersey? Complete 2025 Appeal Guide & Alternative Coverage Options

Answer Box: Natpara was discontinued by Takeda in December 2024, making new prescriptions impossible. If denied coverage for alternative parathyroid hormone treatments like Yorvipath, New Jersey patients can appeal through UnitedHealthcare's internal process (180 days), then New Jersey's Independent Health Care Appeals Program (IHCAP) via Maximus

Getting Natpara (Parathyroid Hormone) Coverage from Aetna CVS Health in New York: 2025 Discontinuation Guide and Alternative Options

Answer Box: Natpara Coverage Status in New York Natpara (parathyroid hormone) is no longer available for new prescriptions as Takeda discontinued global manufacturing in December 2024. Aetna CVS Health automatically denies all new Natpara requests regardless of medical necessity. For New York patients: 1) Discuss Yorvipath (FDA-approved August 2024) with

Renewing Natpara (Parathyroid Hormone) Approval with Cigna in New York: 2025 Discontinuation Guide

Answer Box: Renewing Natpara with Cigna in New York Current Natpara patients can renew coverage with Cigna through December 2025, but must act quickly due to Takeda's global discontinuation. Submit renewal requests 90 days before expiration with updated labs (serum calcium, PTH, 25-OH vitamin D), endocrinologist documentation of

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in Texas: Appeals Guide for Discontinued Drug

Answer Box: Getting Natpara (Parathyroid Hormone) Covered by Cigna in Texas Important: Natpara was discontinued by Takeda in December 2024, with the U.S. Special Use Program ending December 31, 2025. New prescriptions are no longer available. However, if you received a Cigna denial for Natpara before discontinuation or need

How to Get Natpara (Parathyroid Hormone) Covered by Humana in New York: Appeals Guide for Discontinued Drug

Answer Box: Natpara Coverage Status Natpara (parathyroid hormone) is permanently discontinued as of December 31, 2025. Humana automatically denies new Natpara prescriptions because there's no commercial supply. Instead, focus on getting alternative treatments covered like optimized calcium/calcitriol or Yorvipath. For Humana Medicare denials in New York, you

How to Get Natpara (Parathyroid Hormone) Covered by Cigna in North Carolina: Complete 2025 Appeals Guide

Answer Box Getting Natpara (parathyroid hormone) covered by Cigna in North Carolina requires understanding that Takeda discontinued manufacturing in December 2024. New starts are typically denied due to lack of commercial supply. For existing patients, you'll need prior authorization showing chronic hypoparathyroidism, failed conventional therapy (calcium + active vitamin

Getting Natpara (Parathyroid Hormone) Covered by Aetna CVS Health in Pennsylvania: 2026 Discontinuation Guide and Alternative Coverage

Answer Box: Natpara Coverage Status with Aetna CVS Health in Pennsylvania Natpara (parathyroid hormone) is no longer available as Takeda discontinued manufacturing in December 2024, with the U.S. Special Use Program ending December 31, 2025. Aetna CVS Health now automatically denies new Natpara prescriptions due to lack of commercial

How to Get Natpara (Parathyroid Hormone) Covered by UnitedHealthcare in Virginia: 2025 Discontinuation Guide and Appeals Process

Answer Box: Quick Path to Coverage Natpara (parathyroid hormone) is no longer commercially available after Takeda's December 2024 discontinuation. UnitedHealthcare now denies new prescription requests, but existing patients in the Special Use Program may qualify for coverage through December 2025 with proper prior authorization. First step: Contact your